Influenza A viruses escape from MxA restriction at the expense of efficient nuclear vRNP import

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Götz, Veronika ^a   Magar, Linda ^a   Dornfeld, Dominik ^a   Giese, Sebastian ^a   Pohlmann, Anne ^b   Höper, Dirk ^b   Kong, Byung Whi ^c   Jans, David A ^d   Beer, Martin ^b   Haller, Otto ^a   Schwemmle, Martin ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b FEDERAL RESEARCH INSTITUTE FOR ANIMAL HEALTH   (Germany)

^c UNIVERSITY OF ARKANSAS   (United States)

^d MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CORE PROTEIN; MX1 PROTEIN, HUMAN; MYXOVIRUS RESISTANCE PROTEIN; NP PROTEIN, INFLUENZA A VIRUS; RNA BINDING PROTEIN;

A-549 CELL LINE; AMINO ACID SUBSTITUTION; ANIMAL; BIRD; CELL LINE; CHEMISTRY; DOG; GENETICS; HEK293 CELL LINE; HUMAN; INFLUENZA A VIRUS (H5N1); MDCK CELL LINE; METABOLISM; MOLECULAR MODEL; MUTATION; PATHOGENICITY; PROTEIN CONFORMATION; PROTEIN TRANSPORT; VIROLOGY;

A549 CELLS; AMINO ACID SUBSTITUTION; ANIMALS; BIRDS; CELL LINE; DOGS; HEK293 CELLS; HUMANS; INFLUENZA A VIRUS, H5N1 SUBTYPE; MADIN DARBY CANINE KIDNEY CELLS; MODELS, MOLECULAR; MUTATION; MYXOVIRUS RESISTANCE PROTEINS; PROTEIN CONFORMATION; PROTEIN TRANSPORT; RNA-BINDING PROTEINS; VIRAL CORE PROTEINS;

EID: 84961806329     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep23138     Document Type: Article

References (55)

1. Klenk, H. D. Influenza viruses en route from birds to man. Cell Host Microbe 15, 653-654 (2014).
2. Miller, M. S., Palese, P. Peering into the crystal ball: influenza pandemics and vaccine efficacy. Cell 157, 294-299 (2014).
3. Hatta, M., Kawaoka, Y. The continued pandemic threat posed by avian influenza viruses in Hong Kong. Trends Microbiol. 10, 340-344 (2002).
4. WHO. Influenza at the Human-Animal Interface (HAI) http://www.who.int/influenza/human-animal-interface/en/(accessed 16 October 2015).
5. Neumann, G., Kawaoka, Y. Transmission of influenza A viruses. Virology 479-480, 234-246 (2015).
6. Manz, B., Schwemmle, M., Brunotte, L. Adaptation of avian influenza A virus polymerase in mammals to overcome the host species barrier. J. Virol. 87, 7200-7209 (2013).
7. Cauldwell, A. V., Long, J. S., Moncorge, O., Barclay, W. S. Viral determinants of influenza A virus host range. J. Gen. Virol. 95, 1193-1210 (2014).
8. Linster, M. et al. Identification, characterization, and natural selection of mutations driving airborne transmission of A/H5N1 virus. Cell 157, 329-339 (2014).
9. Matrosovich, M. N. et al. Avian influenza A viruses differ from human viruses by recognition of sialyloligosaccharides and gangliosides and by a higher conservation of the HA receptor-binding site. Virology 233, 224-234 (1997).
10. Herfst, S. et al. Airborne transmission of influenza A/H5N1 virus between ferrets. Science 336, 1534-1541 (2012).
11. Imai, M. et al. Experimental adaptation of an influenza H5 HA confers respiratory droplet transmission to a reassortant H5 HA/H1N1 virus in ferrets. Nature 486, 420-428 (2012).
12. Hatta, M., Gao, P., Halfmann, P., Kawaoka, Y. Molecular basis for high virulence of Hong Kong H5N1 influenza A viruses. Science 293, 1840-1842 (2001).
13. Gabriel, G. et al. Differential use of importin-alpha isoforms governs cell tropism and host adaptation of influenza virus. Nat. Commun. 2, 156 (2011).
14. Chen, H. et al. Properties and dissemination of H5N1 viruses isolated during an influenza outbreak in migratory waterfowl in western China. J. Virol. 80, 5976-5983 (2006).
15. Neumann, G., Macken, C. A., Karasin, A. I., Fouchier, R. A., Kawaoka, Y. Egyptian H5N1 influenza viruses-cause for concern? PLoS Pathog. 8, e1002932 (2012).
16. Sawyer, S. L., Elde, N. C. A cross-species view on viruses. Curr. Opin. Virol. 2, 561-568 (2012).
17. Everitt, A. R. et al. IFITM3 restricts the morbidity and mortality associated with influenza. Nature 484, 519-523 (2012).
18. Duggal, N. K., Emerman, M. Evolutionary conflicts between viruses and restriction factors shape immunity. Nat. Rev. Immunol. 12, 687-695 (2012).
19. Mitchell, P. S., Emerman, M., Malik, H. S. An evolutionary perspective on the broad antiviral specificity of MxA. Curr. Opin. Microbiol. 16, 493-499 (2013).
20. Diamond, M. S., Farzan, M. The broad-spectrum antiviral functions of IFIT and IFITM proteins. Nat. Rev. Immunol. 13, 46-57 (2013).
21. Haller, O., Staeheli, P., Schwemmle, M., Kochs, G. Mx GTPases: dynamin-like antiviral machines of innate immunity. Trends Microbiol. 23, 154-163 (2015).
22. Goujon, C. et al. Human MX2 is an interferon-induced post-entry inhibitor of HIV-1 infection. Nature 502, 559-562 (2013).
23. Kane, M. et al. MX2 is an interferon-induced inhibitor of HIV-1 infection. Nature 502, 563-566 (2013).
24. Fricke, T. et al. MxB binds to the HIV-1 core and prevents the uncoating process of HIV-1. Retrovirology 11, 68 (2014).
25. Busnadiego, I. et al. Host and viral determinants of Mx2 antiretroviral activity. J. Virol. 88, 7738-7752 (2014).
26. Bazzigher, L., Schwarz, A., Staeheli, P. No enhanced influenza virus resistance of murine and avian cells expressing cloned duck Mx protein. Virology 195, 100-112 (1993).
27. Bernasconi, D., Schultz, U., Staeheli, P. The interferon-induced Mx protein of chickens lacks antiviral activity. J. Interferon Cytokine Res. 15, 47-53 (1995).
28. Verhelst, J., Hulpiau, P., Saelens, X. Mx proteins: antiviral gatekeepers that restrain the uninvited. Microbiol. Mol. Biol. Rev. 77, 551-566 (2013).
29. Xiao, H., Killip, M. J., Staeheli, P., Randall, R. E., Jackson, D. The human interferon-induced MxA protein inhibits early stages of influenza A virus infection by retaining the incoming viral genome in the cytoplasm. J. Virol. 87, 13053-13058 (2013).
30. Zimmermann, P., Manz, B., Haller, O., Schwemmle, M., Kochs, G. The viral nucleoprotein determines Mx sensitivity of influenza A viruses. J. Virol. 85, 8133-8140 (2011).
31. Huang, T., Pavlovic, J., Staeheli, P., Krystal, M. Overexpression of the influenza virus polymerase can titrate out inhibition by the murine Mx1 protein. J. Virol. 66, 4154-4160 (1992).
32. Dittmann, J. et al. Influenza A virus strains differ in sensitivity to the antiviral action of Mx-GTPase. J. Virol. 82, 3624-3631 (2008).
33. Manz, B. et al. Pandemic influenza A viruses escape from restriction by human MxA through adaptive mutations in the nucleoprotein. PLoS Pathog. 9, e1003279 (2013).
34. Manz, B., Matrosovich, M., Bovin, N., Schwemmle, M. A polymorphism in the hemagglutinin of the human isolate of a highly pathogenic H5N1 influenza virus determines organ tropism in mice. J. Virol. 84, 8316-8321 (2010).
35. Kongchanagul, A. et al. Positive selection at the receptor-binding site of haemagglutinin H5 in viral sequences derived from human tissues. J. Gen. Virol. 89, 1805-1810 (2008).
36. Gabriel, G. et al. The viral polymerase mediates adaptation of an avian influenza virus to a mammalian host. Proc. Natl. Acad. Sci. USA 102, 18590-18595 (2005).
37. Vreede, F. T., Jung, T. E., Brownlee, G. G. Model suggesting that replication of influenza virus is regulated by stabilization of replicative intermediates. J. Virol. 78, 9568-9572 (2004).
38. Cros, J. F., Garcia-Sastre, A., Palese, P. An unconventional NLS is critical for the nuclear import of the influenza A virus nucleoprotein and ribonucleoprotein. Traffic 6, 205-213 (2005).
39. Hutchinson, E. C., Fodor, E. Nuclear import of the influenza A virus transcriptional machinery. Vaccine 30, 7353-7358 (2012).
40. Martin, K., Helenius, A. Transport of incoming influenza virus nucleocapsids into the nucleus. J. Virol. 65, 232-244 (1991).
41. O'Neill, R. E., Jaskunas, R., Blobel, G., Palese, P., Moroianu, J. Nuclear import of influenza virus RNA can be mediated by viral nucleoprotein and transport factors required for protein import. J. Biol. Chem. 270, 22701-22704 (1995).
42. Wu, W. W., Sun, Y. H., Pante, N. Nuclear import of influenza A viral ribonucleoprotein complexes is mediated by two nuclear localization sequences on viral nucleoprotein. Virol. J. 4, 49 (2007).
43. Wagstaff, K. M., Jans, D. A. Importins and beyond: non-conventional nuclear transport mechanisms. Traffic 10, 1188-1198 (2009).
44. Kaur, G., Jans, D. A. Dual nuclear import mechanisms of sex determining factor SRY: intracellular Ca2+ as a switch. FASEB J. 25, 665-675 (2011).
45. Wagstaff, K. M., Rawlinson, S. M., Hearps, A. C., Jans, D. A. An AlphaScreen(R)-based assay for high-throughput screening for specific inhibitors of nuclear import. J. Biomol. Screen 16, 192-200 (2011).
46. Tay, M. Y. et al. Nuclear localization of dengue virus (DENV) 1-4 non-structural protein 5; protection against all 4 DENV serotypes by the inhibitor Ivermectin. Antiviral Res. 99, 301-306 (2013).
47. Wagstaff, K. M., Sivakumaran, H., Heaton, S. M., Harrich, D., Jans, D. A. Ivermectin is a specific inhibitor of importin alpha/betamediated nuclear import able to inhibit replication of HIV-1 and dengue virus. Biochem. J. 443, 851-856 (2012).
48. Fraser, J. E. et al. A nuclear transport inhibitor that modulates the unfolded protein response and provides in vivo protection against lethal dengue virus infection. J. Infect. Dis. 210, 1780-1791 (2014).
49. Caly, L., Wagstaff, K. M., Jans, D. A. Nuclear trafficking of proteins from RNA viruses: potential target for antivirals? Antiviral Res 95, 202-206 (2012).
50. Neumann, G., Macken, C. A., Kawaoka, Y. Identification of amino acid changes that may have been critical for the genesis of A(H7N9) influenza viruses. J. Virol. 88, 4877-4896 (2014).
51. Riegger, D. et al. The nucleoprotein of newly emerged H7N9 influenza A virus harbors a unique motif conferring resistance to antiviral human MxA. J. Virol. 89, 2241-2252 (2015).
52. Juozapaitis, M. et al. An infectious bat-derived chimeric influenza virus harbouring the entry machinery of an influenza A virus. Nat. Commun. 5, 4448 (2014).
53. Hoffmann, E., Neumann, G., Kawaoka, Y., Hobom, G., Webster, R. G. A DNA transfection system for generation of influenza A virus from eight plasmids. Proc. Natl. Acad. Sci. USA 97, 6108-6113 (2000).
54. Manz, B., Brunotte, L., Reuther, P., Schwemmle, M. Adaptive mutations in NEP compensate for defective H5N1 RNA replication in cultured human cells. Nat. Commun. 3, 802 (2012).
55. Banerjee, I., Yamauchi, Y., Helenius, A., Horvath, P. High-content analysis of sequential events during the early phase of influenza A virus infection. PLoS One 8, e68450 (2013).